الصفحة الرئيسية>>Signaling Pathways>> Apoptosis>> Other Apoptosis>>Nimustine hydrochloride

Nimustine hydrochloride (Synonyms: ACNU, NSC-D 245382)

رقم الكتالوجGC36743

Nimustine hydrochloride (ACNU) هو عامل ربط متقاطع للحمض النووي وعامل ألكلة للحمض النووي ، والذي يحفز آفات منع تكرار الحمض النووي وفواصل الحمض النووي المزدوج وتثبيط تخليق الحمض النووي ، الذي يشيع استخدامه في العلاج الكيميائي للأورام الأرومية الدبقية

Products are for research use only. Not for human use. We do not sell to patients.

Nimustine hydrochloride التركيب الكيميائي

Cas No.: 55661-38-6

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
52٫00
متوفر
5mg
46٫00
متوفر
10mg
74٫00
متوفر
50mg
232٫00
متوفر
100mg
417٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Nimustine hydrochloride (ACNU) is a DNA cross-linking and DNA alkylating agent, which induces DNA replication blocking lesions and DNA double-strand breaks and inhibits DNA synthesis, commonly used in chemotherapy for glioblastomas[1][2][3].

[1]. Tomicic MT, et al. Apoptosis induced by temozolomide and nimustine in glioblastoma cells is supported by JNK/c-Jun-mediated induction of the BH3-only protein BIM. Oncotarget. 2015 Oct 20;6(32):33755-68. [2]. Kondo N, et al. FANCD1/BRCA2 plays predominant role in the repair of DNA damage induced by ACNU or TMZ. PLoS One. 2011 May 9;6(5):e19659. [3]. Mineura K, et al. DNA lability induced by nimustine and ramustine in rat glioma cells. J Neurol Neurosurg Psychiatry. 1988 Nov;51(11):1391-4.

مراجعات

Review for Nimustine hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 5 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Nimustine hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.